Swiss National Bank Relay Therapeutics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 219,600 shares of RLAY stock, worth $944,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,600

Previous 167,800 30.87%

Holding current value

$944,280

Previous $1.09 Million 42.05%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$6.23 - $9.51 $322,714 - $492,618	51,800 Added 30.87%	219,600 $1.55 Million
Q2 2024 Aug 08, 2024	BUY	$5.9 - $8.02 $25,370 - $34,486	4,300 Added 2.63%	167,800 $1.09 Million
Q1 2024 May 07, 2024	BUY	$7.5 - $12.07 $53,250 - $85,697	7,100 Added 4.54%	163,500 $1.36 Million
Q4 2023 Feb 06, 2024	SELL	$6.01 - $11.48 $104,574 - $199,752	-17,400 Reduced 10.01%	156,400 $1.72 Million
Q3 2023 Nov 08, 2023	BUY	$8.24 - $12.97 $16,480 - $25,940	2,000 Added 1.16%	173,800 $1.46 Million
Q2 2023 Aug 09, 2023	BUY	$9.99 - $18.27 $20,979 - $38,367	2,100 Added 1.24%	171,800 $2.16 Million
Q1 2023 May 10, 2023	SELL	$15.0 - $22.76 $285,000 - $432,440	-19,000 Reduced 10.07%	169,700 $2.79 Million
Q4 2022 Feb 08, 2023	BUY	$14.16 - $24.02 $53,808 - $91,276	3,800 Added 2.06%	188,700 $2.82 Million
Q3 2022 Nov 09, 2022	BUY	$18.07 - $31.37 $576,433 - $1 Million	31,900 Added 20.85%	184,900 $4.14 Million
Q2 2022 Aug 09, 2022	BUY	$13.31 - $34.88 $676,148 - $1.77 Million	50,800 Added 49.71%	153,000 $2.56 Million
Q1 2022 May 09, 2022	BUY	$20.26 - $32.36 $178,288 - $284,768	8,800 Added 9.42%	102,200 $3.06 Million
Q4 2021 Feb 08, 2022	BUY	$26.0 - $37.03 $569,400 - $810,957	21,900 Added 30.63%	93,400 $2.87 Million
Q3 2021 Nov 08, 2021	BUY	$29.75 - $37.99 $53,550 - $68,382	1,800 Added 2.58%	71,500 $2.25 Million
Q2 2021 Aug 06, 2021	BUY	$27.5 - $38.19 $220,000 - $305,520	8,000 Added 12.97%	69,700 $2.55 Million
Q1 2021 May 07, 2021	BUY	$32.52 - $61.53 $22,764 - $43,071	700 Added 1.15%	61,700 $2.13 Million
Q4 2020 Feb 05, 2021	BUY	$35.51 - $54.03 $2.17 Million - $3.3 Million	61,000 New	61,000 $2.54 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $517M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Relay Therapeutics, Inc. Transaction History